Intravenous naftidrofuryl for critical limb ischaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Naftidrofuryl for Critical Limb Ischaemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434897/all/Intravenous_naftidrofuryl_for_critical_limb_ischaemia.
Intravenous naftidrofuryl for critical limb ischaemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434897/all/Intravenous_naftidrofuryl_for_critical_limb_ischaemia. Accessed January 19, 2025.
Intravenous naftidrofuryl for critical limb ischaemia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434897/all/Intravenous_naftidrofuryl_for_critical_limb_ischaemia
Intravenous Naftidrofuryl for Critical Limb Ischaemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434897/all/Intravenous_naftidrofuryl_for_critical_limb_ischaemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous naftidrofuryl for critical limb ischaemia
ID - 434897
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434897/all/Intravenous_naftidrofuryl_for_critical_limb_ischaemia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -